New treatment for open-angle glaucoma or high eye pressure
Part of Eyes & vision clinical trials.
This trial tests an investigational drug called REGN22530 for people with mild to moderate primary open-angle glaucoma or ocular hypertension (high eye pressure). The goal is to see if it can safely lower eye pressure and protect vision.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have primary open-angle glaucoma or high eye pressure that is mild to moderate.
- Your vision in the study eye is at least 20/200 (with glasses or contacts).
- Your vision in the other eye is at least 20/80 (with glasses or contacts).
- You have not had certain types of glaucoma surgery in the past (like trabeculectomy or a tube shunt).
- You have not had a laser treatment for glaucoma in the last 6 months (like SLT) or certain other laser in the last year.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a gene therapy treatment called GVB-2001 for people with primary open angle glaucoma. It involves a one-time injection into the eye to help lower eye pressure, and could be an option if you have tried other treatments that haven't worked well enough.
This trial tests a new medicine called HUC3-637 for people with primary open-angle glaucoma or ocular hypertension. It aims to see if it safely lowers eye pressure.
This study tests a new eye drop against an existing one to see which better lowers eye pressure in people with open-angle glaucoma or ocular hypertension. You may be able to join if you have high eye pressure in both eyes that needs treatment and you are at least 18 years old.
This trial tests a new eye drop combination (TFC-003) to lower eye pressure in people with primary open-angle glaucoma or ocular hypertension. It compares the new drug to existing treatments to see if it works better or is safer.
This trial tests a surgery that combines cataract removal with a new technique to lower eye pressure in people who have both primary open-angle glaucoma and cataracts. It aims to see if this combined surgery is safe and effective.
This trial tests an investigational eye drop called ASP2767 to see if it is safe and can help slow or prevent further vision loss in people with advanced glaucoma-related optic nerve damage.
Hear when a new Ocular Hypertension (OHT) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.